Cade
Cade Partners is an operator-led US healthcare investment firm that combines majority equity partnerships with an AI-native operating platform (Cade Operator Core) for owner-led healthcare businesses with $2M–$15M EBITDA, targeting clinical workflow automation and verified EBITDA improvement.
- Company typePrivate
- Founded2025
- HeadquartersSan Francisco, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Cade does
Cade Partners is an operator-led healthcare investment firm headquartered at 595 Pacific Ave, San Francisco, founded in 2025 by Kate Juenger, who previously built TeleClinic into Germany's No. 1 healthcare app. The firm runs a majority partnership model targeting owner-led US healthcare and life sciences businesses with $2M–$15M EBITDA — typically taking 65% ownership, 3 of 5 board seats, and embedding forward-deployed AI engineers alongside management, with geographic focus on the Sun Belt, Mountain West, and Mid-Atlantic regions.
The core offering is the Cade Partner Program, a governed 12-month AI initiative delivered through the Cade Operator Core platform across three phases: a 100-Day Diagnostic, a 9-Month Deployment, and an AI Operating Model. The underlying technology stack includes proprietary agentic automation that navigates legacy EHRs (e.g., Epic) without API integrations, a unified data warehouse with natural-language querying, executive dashboards for contribution margin and provider productivity, and AI-powered patient acquisition tooling. Cade reports verified operational outcomes including +$380K Revenue Cycle, +$290K Workforce, and +$210K Growth EBITDA uplift within the first 12 months.
Commercially, Cade operates a performance-linked model: program leadership fees plus performance fees tied to verified EBITDA improvement, supplemented by equity participation for full hold-period alignment. Distribution is direct and capacity-capped at two deployment cohorts per year, supported by The Connected Physician podcast (53 episodes), the Cade Insights blog, and a newsletter. Named reference customers include DashCare Group (portfolio support) and HCAP Partners (PE diligence and operational support).
Cade firmographics
Firmographics- Name
- Cade
- Legal name
- Cade Partners
- Website
- https://cadepartners.com
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Cade Partners is an operator-led US healthcare investment firm that combines majority equity partnerships with an AI-native operating platform (Cade Operator Core) for owner-led healthcare businesses with $2M–$15M EBITDA, targeting clinical workflow automation and verified EBITDA improvement.
- Ownership category
- akta.pro rank
Cade industry classification
Industry- Product category
- Healthcare Private Equity & AI Operational Transformation
- NAICS
- Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro industry
- Corporate Venture Capital (CVC)
Keywords
Where Cade is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Cade business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Performance-Linked Investment Management: Cade generates returns through majority equity partnerships in healthcare businesses. Their fee model includes program leadership fees plus performance fees tied to verified EBITDA improvement. They also take equity participation for complete alignment across the hold period. Revenue is generated from operational value creation and eventual exit proceeds.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Outcome Based/ Performance | Multi-year contract | Performance-Linked Program Fees |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Cade product offering
Product offeringCore offering
Cade Partners is an operator-led healthcare investment firm that takes majority equity stakes in owner-led healthcare and life sciences businesses ($2M–$15M EBITDA) and runs a 12-month AI transformation program through its proprietary Cade Operator Core platform. The firm embeds forward-deployed AI engineers and operates proprietary agentic AI agents across billing, scheduling, clinical workflows, and patient acquisition to drive verified EBITDA improvement during a multi-year hold period.
Product overview
Cade Partners is an operator-led healthcare investment firm that combines capital with AI-native technology infrastructure. The core offering is the Cade Partner Program, a 12-month governed AI initiative structured around three phases delivered through the Cade Operator Core: the 100-Day Diagnostic, 9-Month Deployment, and AI Operating Model. The platform is supplemented by specialized modules including Executive Dashboards (live metrics), Agentic Automation (EHR navigation without APIs), Data Architecture (unified warehouse with natural language querying), and Generative Acquisition (AI-driven patient growth). The Connected Physician Podcast serves as the company's media and research arm, publishing insights on clinical AI, healthcare operations, and market dynamics. The company operates exclusively in healthcare and life sciences, focusing on proven, owner-led businesses with EBITDA of $2M–$15M in the Sun Belt, Mountain West, and Mid-Atlantic regions.
Differentiator
Problem solved
Functional benefit
Brands
- The Connected Physician: A podcast hosted by Katharina Juenger exploring the intersection of healthcare, technology, and leadership, featuring conversations with top healthcare professionals on how AI is transforming patient care.
- Cade OS
Products and services
- Cade Partner Program A governed 12-month AI transformation program for healthcare investors and portfolio operators that turns operational complexity into measurable enterprise value. Structured as three phases — 100-Day Diagnostic, 9-Month Deployment, and AI Operating Model — it bundles forward-deployed AI engineers, proprietary agentic AI, board governance, and performance-linked fees aligned to verified EBITDA improvement. Targeted at founder-led healthcare businesses with $2M–$15M EBITDA and at healthcare-focused PE funds seeking operational value creation.
Quantifiable outcome
- Revenue Cycle improvement of +$380K in verified EBITDA within first 12 months
- +6 more outcomes
Companies that use Cade
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles2 records
Cade technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability7 records
Feature5 records
Cade partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights6 records
Cade competitors and assessment
Company assessmentBroad incumbents
- General Atlantic: Global growth equity investor with a substantial healthcare services franchise; overlaps on healthcare operating leverage and minority/majority growth structures.
- New Mountain Capital: Growth-oriented PE firm with concentrated healthcare services exposure and a strong operating partner program; comparable on thesis-driven mid-market healthcare investing.
- KKR: Global PE platform with a dedicated healthcare strategic growth franchise; relevant incumbent that could replicate AI-native operating capabilities at scale.
- Welsh, Carson, Anderson & Stowe: Healthcare-dominant middle-market PE firm with deep operating partner networks and a long track record in physician practice and healthcare services buyouts—directly comparable customer base (owner-led healthcare founders) and deal-size band.
- Bain Capital: Large diversified PE platform with a deep healthcare vertical and operating-partner playbook; competitive bidder on the same founder-led healthcare auctions Cade targets.
Direct peers
- Avista Capital Partners: Healthcare-focused middle-market PE firm investing in services, pharma, and medtech; most comparable on healthcare-only vertical and mid-market check sizes.
- Linden Capital Partners: Healthcare-specialist middle-market PE firm focused on founder-led healthcare businesses; most direct comparator in deal size, vertical, and operator-led underwriting style.
- Frazier Healthcare Partners: Dedicated healthcare PE platform investing across services, pharma services, and IT; overlaps with Cade on lower-middle-market healthcare services with operational value-creation emphasis.
- TT Capital Partners: Healthcare tech and services growth investor; closest comparator on the technology-enabled healthcare services thesis and growth-equity orientation.
Emerging players
- Andreessen Horowitz (a16z Bio + Health): Tech-bio crossover investor pairing capital with operating support and technical talent; partial overlap on thesis that AI-native platforms reshape healthcare investing and company-building.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights5 records
Customer concentration
Cade social profiles
Digital presenceCade financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cade leadership team
Management profileNumber of profiles
Profiles1 record
Cade funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cade M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cade
What does Cade do?
Cade Partners is an operator-led healthcare investment firm that takes majority equity stakes in owner-led healthcare and life sciences businesses ($2M–$15M EBITDA) and runs a 12-month AI transformation program through its proprietary Cade Operator Core platform. The firm embeds forward-deployed AI engineers and operates proprietary agentic AI agents across billing, scheduling, clinical workflows, and patient acquisition to drive verified EBITDA improvement during a multi-year hold period.
Is Cade a public or private company?
Cade is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Cade founded?
Cade was founded in 2025. It employs 1 to 10 people.
Where is Cade based?
Cade is headquartered in San Francisco, United States, in the North America region.
How does Cade make money?
One revenue line is on record: performance-Linked Investment Management.
Who are Cade's main competitors?
Broad incumbents on record are General Atlantic, New Mountain Capital, KKR, Welsh, Carson, Anderson & Stowe and Bain Capital. Direct peers are Avista Capital Partners, Linden Capital Partners, Frazier Healthcare Partners and TT Capital Partners. Andreessen Horowitz (a16z Bio + Health) is listed as an emerging player.
Does Cade have an API?
No public API is recorded for Cade.
What industry is Cade in?
Cade's product category is Healthcare Private Equity & AI Operational Transformation. Its primary akta.pro industry code is FSANAAAF, Corporate Venture Capital (CVC). Its NAICS code is 523940 and its SIC code is 6282.